Sabree Burbage, PharmD

Associate Director, Real World Value & Evidence
Johnson & Johnson Innovative Medicine

Poster(s):

• (384) Economic burden among patients with high-risk and low-to-intermediate-risk localized prostate cancer receiving radical prostatectomy in the United States
  Wednesday, October 29, 2025